Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending September 27, 2015

Neurogranin Levels as Alzheimer Biomarker, Does elevation signal cognitive decline?

Guideline on Status Epilepticus, ILAE revises concepts, definition, and classification

Progression to Dementia in Parkinson Disease, Uncovering predictors of decline

Serum Sphingolipid Panels in Migraine, Do they have predictive value?

Sleep and the Common Cold, Associating duration with susceptibility

More must reads

Must reads for theWeek ending September 20, 2015

CNS Tissue Destruction in MS, Novel MRI scale measures extent of damage

Breastfeeding in Relapsing-Remitting MS, Does it increase relapse risk?

Assessing Balance Impairment, Correlating inertial sensors with standard scales

MS and Tremor in US Dentists, Does mercury exposure increase risks?

Predicting Disability in Relapse Onset MS, Associating motor network efficiency with EDDS score

More must reads

Must reads for theWeek ending September 13, 2015

Must reads for theWeek ending August 30, 2015

Reperfusion Time in Stroke, Associating OTR with outcome

Distinguishing Parkinson’s Disease, New model separates patients from controls

Perampanel in Idiopathic Generalized Epilepsy, Does it reduce PGTC seizures?

GBA Mutations and E326K in Parkinson’s Disease, Studying their effect on dementia and function

Obstructive Sleep Apnea After Surgery, Does OSA affect cardiopulmonary complications?

More must reads

Must reads for theWeek ending August 16, 2015

FDA Approves First 3D-Printed Drug, Spritam indicated for epilepsy

Total Tau in Traumatic Brain Injury, Does it correlate with postconcussive symptoms?

Stroke and CV Events in Migraine Patients, Studying associations in a diverse cohort

Insulin Resistance in Cognitive Function, When should treatment be initiated?

Solanezumab in Mild Alzheimer Disease, Assessing safety and efficacy

More must reads

Pages